Beta-blocker Heart Attack Trial

Beta-blocker Heart Attack Trial
Author :
Publisher :
Total Pages : 8
Release :
ISBN-10 : MINN:319510028407364
ISBN-13 :
Rating : 4/5 ( Downloads)

Book Synopsis Beta-blocker Heart Attack Trial by : National Institutes of Health (U.S.)

Download or read book Beta-blocker Heart Attack Trial written by National Institutes of Health (U.S.) and published by . This book was released on 1978 with total page 8 pages. Available in PDF, EPUB and Kindle. Book excerpt:


Beta-blocker Heart Attack Trial Related Books

Beta-blocker Heart Attack Trial
Language: en
Pages: 8
Authors: National Institutes of Health (U.S.)
Categories: Adrenergic beta blockers
Type: BOOK - Published: 1978 - Publisher:

DOWNLOAD EBOOK

The Modern Role of Beta-Blockers in Cardiovascular Medicine
Language: en
Pages: 286
Authors: J. M. Cruickshank
Categories: Adrenergic beta blockers
Type: BOOK - Published: 2010-09 - Publisher: PMPH-USA

DOWNLOAD EBOOK

The book provides a concise much-needed update of beta-blockers use cardiovascular area (particularly hypertension and heart failure). It will uncover the clini
The ESC Textbook of Preventive Cardiology
Language: en
Pages: 369
Authors: Stephan Gielen
Categories: Medical
Type: BOOK - Published: 2015 - Publisher: European Society of Cardiology

DOWNLOAD EBOOK

"EACPR, European Association for Cardiovascular Prevention and Rehabilitation -- European Society of Cardiology."
Rutherford's Vascular Surgery and Endovascular Therapy, E-Book
Language: en
Pages: 2838
Authors: Anton N Sidawy
Categories: Medical
Type: BOOK - Published: 2018-04-03 - Publisher: Elsevier Health Sciences

DOWNLOAD EBOOK

Through nine outstanding editions, Rutherford's Vascular Surgery and Endovascular Therapy has been the gold standard text in this fast-changing, complex field.
Disease Control Priorities, Third Edition (Volume 5)
Language: en
Pages: 948
Authors: Dorairaj Prabhakaran
Categories: Medical
Type: BOOK - Published: 2017-11-17 - Publisher: World Bank Publications

DOWNLOAD EBOOK

Cardiovascular, respiratory, and related conditions cause more than 40 percent of all deaths globally, and their substantial burden is rising, particularly in l